Update 6.0 - Besremi Begins: The Besremi journey... - MPN Voice

MPN Voice

10,834 members15,131 posts

Update 6.0 - Besremi Begins

hunter5582 profile image
79 Replies

The Besremi journey began today. I did a baseline CBC two days prior to starting. I was surprised to find out that for the first time since starting on PEG, my HCT had floated up to 45.2%. I hindsight, I had been so tied up with taking care of my Mother in the days prior I may have been a bit lower than usual on hydration. RBCs were not particularly higher than recently. I expect it is just an anomaly. HCT always is just an approximation of your status since it is sensitive to changes in plasma volume, I will be sure to keep up the hydration.

The MPN Specialist had recommended that I start at 50mcg. The doc is being conservative about adverse effects since I am the first Besremi patient at Johns Hopkins MPN Clinic. I had decided to follow the Dr. Mesa recommendation for the 45mcg Pegasys to Besremi conversion of 63mcg. Given that my HCT just popped up a bit for whatever reason, I consulted with the MPN Specialist about starting at 100mcg, which is the standard starting doe of Besremi (unless you are switching from HU). We agreed to start at 100mcg and see how it goes. I will be monitoring at 2 week intervals until we see how the conversion goes.

The first injection went off without a hitch. I do not care for the larger 500mcg syringe since dosing at the lower levels is a bit harder to gauge. It is still doable though. I must say it is disheartening to waste 80% of a medication that costs $7,500/dose. I sure hope PharmaEssentia comes up with a better plan soon.

It will be interesting to see how the switch goes. Will stay in touch as the journey unfolds.

Written by
hunter5582 profile image
hunter5582
To view profiles and participate in discussions please or .
Read more about...
79 Replies
mhos61 profile image
mhos61

Good luck on your new journey.

Paul123456 profile image
Paul123456

Hope it goes well. I pondering a switch since Pegasys has not prevented me from moving from Grade 1 to Grade 2 fibrosis. Wondering if this is down to my second mutation, TET2.Have you studied the differences between Pegasys and Besremi sufficiently in order to have a view on whether Besremi may be more effective in circumventing the inflammatory impact of TET2 on pathways used by Pegasys

Sorry, that’s a bit of a mouthful!

Best Paul

hunter5582 profile image
hunter5582 in reply toPaul123456

The short answer is that Besremi might have greater efficacy, but that is not clear. What is more likely is that the monopegyated formulation would allow greater tolerance, enabling a higher dose to be used. I think that could make a significant difference. I do not think we will really know until there is a larger number of people using Besremi over time.

Paul123456 profile image
Paul123456 in reply tohunter5582

Thanks, my problem is that I’ve had to reduce dosage to only 30 mcg every two weeks since haematological overkill (bloods too low) but I’m now to some extent losing the molecular benefits - JAK2 rising.

So I’m hoping that Besremi may work better on a molecular level, especially against TET2

hunter5582 profile image
hunter5582 in reply toPaul123456

Definatley worth trying if you can get it approved.

Mostew profile image
Mostew

Good to hear your update and no problems so far Hunter . Bet you are right about fluid intake Best wishes

Carolyn

Magentas profile image
Magentas

Congratulations, all the best with the transition and for your mothers comfort.

Buggerbear profile image
Buggerbear

So excited for you and can't wait for you to share your journey with us. Yes, I agree on such a waste! Wish I could share it with you as the cost is unbelievable.

hunter5582 profile image
hunter5582 in reply toBuggerbear

It does really bug me that of the $7,500/dose I am wasting $6,000. It was so hard to get approved due to the cost. This seems like needless waste.

in reply tohunter5582

Much more expensive then in Germany. I think here it’s aprox 2000 € a dose. Good luck with the switch

Manouche profile image
Manouche

Well done Hunter! 100mcg is a very wise decision! I’m convinced that you’ll be fine at this dosage!

Solyesh profile image
Solyesh

Hunter - thanks and best of luck!

EPguy profile image
EPguy

Quite exciting. Do you have any recent allele % ?

I am very near starting Bes. I will get the 1st one at the Dr office. He wants to do 1st shots there, I'm more than happy to do that.

My Ins co has approved it. Is it right that the 500mcg syringe is thrown away after one use?

In the UK it comes in either 250mcg or 500 and can be used twice. I now see that US is not following this.

medicines.org.uk/emc/produc...

<<The pre-filled pen may not be used more than twice and must be discarded 30 days after the first use, regardless of any medicinal product remaining in the pre-filled pen.>>

So up to 125mcg/dose, UK needs only 6 small syringes per year vs 24 big ones here. We are the same only if the dose is maxed at 500 per two weeks.

As usual just like our cars, US is less efficient.

in reply toEPguy

Exciting! You will probably be one of the very few with ET to get Besremi. Here in Germany it’s only available for PV patients unless part of a study. Please keep us posted.

EPguy profile image
EPguy in reply to

My official DX is PV from my 1st Dr even as my indications (BMB, pre Dx bloods) are mostly toward ET. My current Dr says I have "MPN" on the continuum and it's not specific. The lower allele % (I'm 14-19) tends to respond less dramatically to INF, but single mutation (Jak2) tends to good response. I hope to have plenty of stories.

I'm also resuming NAC as approved by my Dr, I had good symptom results in a brief test of my own last month, I described in another post. I should get more info there before my switch to Bes, after which I will continue the NAC.

Kelly2 profile image
Kelly2 in reply toEPguy

Please explain what is NAC?

hunter5582 profile image
hunter5582 in reply toKelly2

N-Acetylcysteine is a supplement that has shown anti-inflammatory efficacy in MPN research by Dr. Angela Fleischman and others.

Kelly2 profile image
Kelly2 in reply tohunter5582

Thank you. I had no idea!

EPguy profile image
EPguy in reply toKelly2

As Hunter says, NAC is being studied right now in an early trial. It has been used since the 1960's for treating Tylenol (Paracetamol) overdose.

There is a mouse study indicating a signif benefit for PV. It goes after many of the bad things that happen in the bodies of MPNs (inflammation and for example it affects "NETosis" and other important things with capital letters)

US FDA is threatening to prohibit it from the supplement market, if so it will require an Rx.

Kelly2 profile image
Kelly2 in reply toEPguy

So the trial is not over yet? But you use it?

hunter5582 profile image
hunter5582 in reply toEPguy

When last checked allele burden October 2020 as 26% on the stand-alone and 29% on the Intelligen Myeloid Panel. MPN Specialist feels the stand-alone was likely more accurate. That was only up 25% the previous year.

It is correct that the only option is a single use 500mcg syringe in the USA. I already voiced concern to PharmaEssentia. Plan to follow up on this as it would be easier to do the lower dosing with a smaller syringe. Also less wasteful. I actually prefer prepping my own syringe from a vial.

Glad to hear the first dose will be at the doc office. It is a good idea to be observed the first time just in case of a very rare more severe reaction. It also helps to get trained if you have never self-injected. It is very easy to do once you know how. I can barely feel it when I inject. Since I was switching from PEG to Besremi, I just chatted with the nurse from the specialty pharmacy. Told her I did not need any further support to be ready to inject. The nurse will call me afterward to see how it went.

I am sure your first injection will be no big deal and the start of a new and successful journey.

EPguy profile image
EPguy in reply tohunter5582

It seems there is an actual medical problem with the current syringe if you're having any trouble at all and it is supposed to be used by a typical inexperienced patient for is low as 50mcg. I'm surprised FDA did not require at least a 250 option. It's part of the Co looking for max $ from the US system.

It comes back to my thought of a compounding pharmacy prepping the doses we need for zero waste. One would think they could put it into insulin pens at the prescribed dose, that would be easiest error proof solution for all. At 7+k per there is more than plenty of money for these contortions.

For in-office, I think my Dr also wants the opportunity to learn in person about his 1st Rx of Bes.

hunter5582 profile image
hunter5582 in reply toEPguy

Definitely an element of fleecing the American market. It is a shame but it is what it is.

The syringe is marked for 50-100 and up, however it would just be a guess to estimate the Mesa recommendation of 63mcg. Oh well, will just do the best I can.

The syringe is very easy to use, just way bigger than I need. Note that there is no difference in the needle size - just the body of the syringe.

I expect you doc might want to see his first Besremi patient but the first admin of any interferon really should be observed. The more severe reaction like anaphylaxis are very rare but better safe than sorry.

Do please let us know how it goes

EPguy profile image
EPguy in reply tohunter5582

Good point on the reaction, I missed that on your prior reply. Same idea as the Covid shots 15 minutes wait.

Elizka profile image
Elizka in reply tohunter5582

Remember, it isn't the drug itself that is expensive per se, its the cost to get the drug approved by the FDA.

hunter5582 profile image
hunter5582 in reply toElizka

The part I find so appalling is that so much has to be wasted. It really should be available in smaller dose increments. Sometimes it just is what it is.

Elizka profile image
Elizka in reply tohunter5582

Totally agree. I'm sure the company will make that happen, especially when they find out how many patients aren't using the 500mcg.

Kelly2 profile image
Kelly2 in reply tohunter5582

Hi Hunter. My deepest condolences for your mom! Be well to remember her. I have hypothyroidism. So Besremi is an interferon? I am not sure if it is suitable for me. I am gathering information from you guys and take notes so that I can ask my doctor when I see him.

Kelly2 profile image
Kelly2 in reply toEPguy

Can we check our allele burden when having PV or is it just for fibrosis?

hunter5582 profile image
hunter5582 in reply toKelly2

You can check allele burden at any time with any f the MPNs

EPguy profile image
EPguy in reply toKelly2

It can be checked either with a blood draw(easy) or from a bone marrow biopsy BMB. (unpleasant).

All MPN patients should have this number at various times in our MPN journey. Fibrosis is evaluated with the BMB, but cannot normally be seen with a blood draw.

Jennytheb profile image
Jennytheb

Hi Hunter, Hope this goes well for you, take care and hope your mother is a little better at least. Will be an interesting journey.

hunter5582 profile image
hunter5582 in reply toJennytheb

Thanks I am doing fine. We will see how it goes over the next couple of weeks.

Thanks for asking after my Mom. She in now within hours of passing. She is resting peacefully and is not in pain. She will soon be in a better place.

Jennytheb profile image
Jennytheb in reply tohunter5582

So sorry to hear about your Mum but when mine died a few years ago I was strangely relieved, as I am sure you will be, that she would not be in any more pain. Felt it was the only way I could cope at that sad time.

hunter5582 profile image
hunter5582 in reply toJennytheb

My Mother will be blessed to pass. She has been through so much in the last several years. It has been progressively worse in the last several months. Sine the hip break on Jan 4 she has just spiraled steadily downhill. One of the last things she was able to say was that she wanted to "sleep in heavenly sleep." She will soon have the chance to reach that peace. It is sad for us but a joy for her. Thanks for the support.

Elizka profile image
Elizka in reply tohunter5582

My thoughts are with you, Hunter. I lost my mom two years ago this month and there are so many days I actually take steps to call her....then I remember. Take care,

hunter5582 profile image
hunter5582 in reply toElizka

Thank you, My Mother was blessed to pass at Noon today. Her passing was peaceful and surrounded by family. She now has her wish to "sleep in heavenly sleep." We will one day be reunited. Until then, we have many good memories of better times.

All the best to you and yours.

Daisyplus4 profile image
Daisyplus4 in reply tohunter5582

Hunter I'm very glad for your Mother's peaceful departure from this broken world, and glad for the hope you have of being reunited. Also, I'm continually grateful for your informed and thoughtful comments on this platform. You must spend a great deal of time checking information and writing to people. Every note, from everybody here, is a gift and a kindness to us.

Cja1956 profile image
Cja1956 in reply tohunter5582

So very sorry to hear about your mom, Hunter. I’m glad she died peacefully surrounded by family. My thoughts and prayers go out to you and your family.

Pat032018 profile image
Pat032018 in reply tohunter5582

Sorry to hear about the loss of your mother. May she rest in peace!

flirt_2015 profile image
flirt_2015

Hope all goes well with you Hunter🤞

DottyDaisy profile image
DottyDaisy

I so agree about the waste. Utterly beyond belief. I was horrified when I learned the price here in the UK of my Peg shot, yet that's peanuts against the waste of your Besremi Hunter.When I asked about re-using the syringe, I met with exactly the same response from everybody. From my doctor, from the phlebotomist and from the hospital: "It is not recommended". Then they repeat the instructions to discard the unused portion of the dose. Only when I heard those exact words for the third time did I get it. They were carefully NOT telling me NOT to do it. So I have been injecting myself with 45 mcl of the 90 in the syringe. I then pop the cap back on the needle and put it back in the fridge for the second dose, 10 days later. Win-win all round. Apart from the saving in cost of the actual drug, my yellow sharps box last twice as long and they only need to courier my prescription down under refrigeration from London half as often. So I feel I am also quietly doing my bit to shore up the heavily stretched and much loved NHS.

Flynn2107 profile image
Flynn2107 in reply toDottyDaisy

I repackage my Pegasys single use vial into three syringes of 0.33 ml (60 mcg) each and use one per week. Syringes are cheap and so am I. Check out cdc guidlines for repackaging, USP 797, here is a web site : cms.gov/Medicare/Provider-E...

DottyDaisy profile image
DottyDaisy in reply toFlynn2107

Well thank you Flynn. That's really helpful. Indeed a third of a dose a week would be preferable to a half every 10 days, as the half life of the Peg, I understand, is only a week anyway. I am one delighted Daisy. My platelets went down rapidly from around 1000 when I started the Peg in July but have now been hovering around the low 500s since October. Hopefully a slight increase in dose plus this better distribution will get me on the operating table by the summer, for my hip replacement. Thank you.

EPguy profile image
EPguy in reply toDottyDaisy

Problem with the US system is no one, including the insured patient, is financially motivated to fix this problem. If we had to pay even a tiny fraction of the $180,000/ year we would be forced to get creative. But I hate to see inefficiency anywhere.

As I note above UK already has more efficiency for Besremi with smaller and double use syringes.

DottyDaisy profile image
DottyDaisy in reply toEPguy

I'm afraid there's not much about this world that I even begin to understand these days.

Hello Hunter, crikey what a journey so much going on for you, your family and your medical team, lm bowled over with all your experiencing right now and lm sending you and yours my prayers and best wishes. Adiewon

FG251 profile image
FG251

There ought to be a way of ‘syringe-pooling’ - like carpooling: sharing the dose and the cost but each bringing our own needles!

EPguy profile image
EPguy in reply toFG251

Right on. If a Dr's office starts to get more Bes patients this could work well with cooperation from a compounding pharmacy. Maybe the dose could go into an individual generic insulin pens (I'm not qualified to make that judgement)

I am the 1st one at my Dr's office and the Rx process has been an experiment in its own right.

FG251 profile image
FG251 in reply toEPguy

Given the sums involved, it’s an outrage that patients are forced to waste these meds. I have to squirt half of my 90mcg syringe into the sharps box each week. We can put men on the moon, but we can’t produce simple 45mcg syringes?

EPguy profile image
EPguy in reply toFG251

It's actually the "men on the moon" precision that got Besremi dosing/delivery to its maximum profits for the maker, via tweaking the US system exactly as required for that goal.

For Bes, it starts at 50 to 100 mcg, and the remaining 400-450 is tossed. If one gets its max dose of 500, then there is no waste. But that max dose will likely be rare.

Threelions profile image
Threelions

Good luck Hunter. You know We’re always right behind you. Continuous thanks for all your posts & thanks in advance for sharing your experience moving forward.

Cja1956 profile image
Cja1956

It’s interesting that you’re the first Besremi patient at Johns Hopkins. Your knowledge and expertise regarding your illness always astonishes me. You’re paving the way for future patients who want to try this drug. I wish you all the best on this next journey.

Olmstmg profile image
Olmstmg

Best of luck Hunter!

Meatloaf9 profile image
Meatloaf9

So sorry to hear that your mother is so near to passing, God speed on her new journey. Best always.

Bluetop profile image
Bluetop

Good luck with it! Keep us informed. As you say, so disappointing to be wasting so much medication with each shot.

josup26 profile image
josup26

Hunter I am most interested in hearing about you new journey. I would like to start speaking with my Hemo before I start medication. Best Wishes.

socrates_8 profile image
socrates_8

Hey Steve... :-)

Belated NY tidings to you & yours my friend...

Hoping that your new trial on Besremi works for you... & I can easily empathise & comprehend the distractions that can occur when caring for one's mother, as I also have such privileges these days...

The CV–19 ramifications, have proved to be one of the greater challenges I've faced in caring for my mother's health, & that is largely due to the aberrant influence of siblings who have chosen to remain unvaccinated. Leading to my 85yo mother's vacillating equivocations concerning the pros & cons of vaccination, (mum also has a rare blood type which may be prone to more severe CV–19 symptoms & outcomes). However, I have just managed to subtly suggest the 3rd Booster will be required if she hopes to have another hip operation shortly etc...

My mother will be 86yo tomorrow, & is planning to have visitors of the unvaccinated genre,which all highlights another of the many dysfunctions the CV–19 pandemic has wrought across family units & society moreover in the past couple of years...

Anyways, back to Besremi Steve... I have read a great deal about many of the known "side-effects" that can occur within a variety of different people etc... Knowing your love of deep research, I am sure that you have seen and considered all that needs consideration...

In Australia, (just as there has been in Europe & the USA), there is a hard push to have Besremi available here too for PV patients on our PBS scheme etc...

One of the more noted side-effects is that of severe depression...

Earlier on in my own treatment, I had trialled Ropeg Interferon, and I too succumbed to intense depression, (along w/ suicidal ideation), during that period...

However, the list that I have recently observed on a Bloomberg article, was far more comprehensive, and I include here below for your further interest...

Obviously, and as we have all learned through our MPN journey, we are all made just a tad differently, and what works for one may not for another etc...

Stay safe, happy & well my friend...

Steve

(Sydney)

Bloomberg article:

PharmaEssentia’s BESREMi® (ropeginterferon alfa-2b-njft) Now Available for

the Treatment of People With Polycythemia Vera in the United States

BESREMi^® is the only therapy indicated for adults with PV regardless of

treatment history

PharmaEssentia introduces holistic services program to support prescribed

patients

Business Wire

BURLINGTON, Mass. -- December 6, 2021

bloomberg.com/press-release...

Important Safety Information

IMPORTANT SAFETY INFORMATION AND INDICATIONS

WARNING: RISK OF SERIOUS DISORDERS

Interferon alfa products may cause or aggravate fatal or life-threatening

neuropsychiatric, autoimmune, ischemic, and infectious disorders. Patients

should be monitored closely with periodic clinical and laboratory evaluations.

Therapy should be withdrawn in patients with persistently severe or worsening

signs or symptoms of these conditions. In many, but not all cases, these

disorders resolve after stopping therapy.

CONTRAINDICATIONS

* Existence of, or history of severe psychiatric disorders, particularly

severe depression, suicidal ideation, or suicide attempt

* Hypersensitivity to interferons including interferon alfa-2b or any of the

inactive ingredients of BESREMi.

* Moderate (Child-Pugh B) or severe (Child-Pugh C) hepatic impairment

* History or presence of active serious or untreated autoimmune disease

* Immunosuppressed transplant recipients

WARNINGS AND PRECAUTIONS

* Depression and Suicide: Life-threatening or fatal neuropsychiatric

reactions have occurred in patients receiving interferon alfa-2b products,

including BESREMi. These reactions may occur in patients with and without

previous psychiatric illness.

Other central nervous system effects, including suicidal ideation, attempted

suicide, aggression, bipolar disorder, mania and confusion have been observed

with other interferon alfa products.

Closely monitor patients for any symptoms of psychiatric disorders and

consider psychiatric consultation and treatment if such symptoms emerge. If

psychiatric symptoms worsen, it is recommended to discontinue BESREMi therapy.

* Endocrine Toxicity: These toxicities may include worsening hypothyroidism

and hyperthyroidism. Do not use BESREMi in patients with active serious or

untreated endocrine disorders associated with autoimmune disease. Evaluate

thyroid function in patients who develop symptoms suggestive of thyroid

disease during BESREMi therapy. Discontinue BESREMi in patients who

develop endocrine disorders that cannot be adequately managed during

treatment with BESREMi.

* Cardiovascular Toxicity: Toxicities may include cardiomyopathy, myocardial

infarction, atrial fibrillation and coronary artery ischemia. Patients

with a history of cardiovascular disorders should be closely monitored for

cardiovascular toxicity during BESREMi therapy. Avoid use of BESREMi in

patients with severe or unstable cardiovascular disease, (e.g.,

uncontrolled hypertension, congestive heart failure (≥ NYHA class 2),

serious cardiac arrhythmia, significant coronary artery stenosis, unstable

angina) or recent stroke or myocardial infarction.

* Decreased Peripheral Blood Counts: These toxicities may include

thrombocytopenia (increasing the risk of bleeding), anemia, and leukopenia

(increasing the risk of infection). Monitor complete blood counts at

baseline, during titration and every 3-6 months during the maintenance

phase. Monitor patients for signs and symptoms of infection or bleeding.

* Hypersensitivity Reactions: Toxicities may include serious, acute

hypersensitivity reactions (e.g., urticaria, angioedema,

bronchoconstriction, anaphylaxis). If such reactions occur, discontinue

BESREMi and institute appropriate medical therapy immediately. Transient

rashes may not necessitate interruption of treatment.

* Pancreatitis: Pancreatitis has occurred in 2.2% of patients receiving

BESREMi. Symptoms may include nausea, vomiting, upper abdominal pain,

bloating, and fever. Patients may experience elevated lipase, amylase,

white blood cell count, or altered renal/hepatic function. Interrupt

BESREMi treatment in patients with possible pancreatitis and evaluate

promptly. Consider discontinuation of BESREMi in patients with confirmed

pancreatitis.

* Colitis: Fatal and serious ulcerative or hemorrhagic/ischemic colitis have

occurred in patients receiving interferon alfa products, some cases

starting as early as 12 weeks after start of treatment. Symptoms may

include abdominal pain, bloody diarrhea, and fever. Discontinue BESREMi in

patients who develop these signs or symptoms. Colitis may resolve within 1

to 3 weeks of stopping treatment.

* Pulmonary Toxicity: Pulmonary toxicity may manifest as dyspnea, pulmonary

infiltrates, pneumonia, bronchiolitis obliterans, interstitial

pneumonitis, pulmonary hypertension, and sarcoidosis. Some events have

resulted in respiratory failure or death. Discontinue BESREMi in patients

who develop pulmonary infiltrates or pulmonary function impairment.

* Ophthalmologic Toxicity: These toxicities may include severe eye disorders

such as retinopathy, retinal hemorrhage, retinal exudates, retinal

detachment and retinal artery or vein occlusion which may result in

blindness. During BESREMi therapy, 23% of patients were identified with an

eye disorder. Eyes disorders ≥5% included cataract (6%) and dry eye (5%).

Advise patients to have eye examinations before and during BESREMi

therapy, specifically in those patients with a retinopathy-associated

disease such as diabetes mellitus or hypertension. Evaluate eye symptoms

promptly. Discontinue BESREMi in patients who develop new or worsening eye

disorders.

* Hyperlipidemia: Elevated triglycerides may result in pancreatitis. Monitor

serum triglycerides before BESREMi treatment and intermittently during

therapy and manage when elevated. Consider discontinuation of BESREMi in

patients with persistently, markedly elevated triglycerides.

* Hepatotoxicity: These toxicities may include increases in serum alanine

aminotransferase (ALT), aspartate aminotransferase (AST), gamma-glutamyl

transferase (GGT) and bilirubin. Liver enzyme elevations have also been

reported in patients after long-term BESREMi therapy. Monitor liver

enzymes and hepatic function at baseline and during BESREMi treatment.

Discontinue BESREMi in patients who develop evidence of hepatic

decompensation (characterized by jaundice, ascites, hepatic

encephalopathy, hepatorenal syndrome or variceal hemorrhage) during

treatment

* Renal Toxicity: Monitor serum creatinine at baseline and during therapy.

Avoid use of BESREMi in patients with eGFR <30 mL/min. Discontinue BESREMi

if severe renal impairment develops during treatment.

* Dental and Periodontal Toxicity: These toxicities may include dental and

periodontal disorders, which may lead to loss of teeth. In addition, dry

mouth could have a damaging effect on teeth and mucous membranes of the

mouth during long-term treatment with BESREMi. Patients should have good

oral hygiene and regular dental examinations.

* Dermatologic Toxicity: These toxicities have included skin rash, pruritus,

alopecia, erythema, psoriasis, xeroderma, dermatitis acneiform,

hyperkeratosis, and hyperhidrosis. Consider discontinuation of BESREMi if

clinically significant dermatologic toxicity occurs.

* Driving and Operating Machinery: BESREMi may impact the ability to drive

and use machinery. Patients should not drive or use heavy machinery until

they know how BESREMi affects their abilities. Patients who experience

dizziness, somnolence or hallucination during BESREMi therapy should avoid

driving or using machinery.

* Embryo-Fetal Toxicity: Based on the mechanism of action, BESREMi can cause

fetal harm when administered to a pregnant woman. Pregnancy testing is

recommended in females of reproductive potential prior to treatment with

BESREMi. Advise females of reproductive potential to use an effective

method of contraception during treatment with BESREMi and for at least 8

weeks after the final dose.

ADVERSE REACTIONS

The most common adverse reactions reported in > 40% of patients in the

PEGINVERA study (n=51) were influenza-like illness, arthralgia, fatigue,

pruritis, nasopharyngitis, and musculoskeletal pain. In the pooled safety

population (n=178), the most common adverse reactions greater than 10%, were

liver enzyme elevations (20%), leukopenia (20%), thrombocytopenia (19%),

arthralgia (13%), fatigue (12%), myalgia (11%), and influenza-like illness

(11%).

DRUG INTERACTIONS

Patients on BESREMi who are receiving concomitant drugs which are CYP450

substrates with a narrow therapeutic index should be monitored to inform the

need for dosage modification for these concomitant drugs. Avoid use with

myelosuppressive agents and monitor patients receiving the combination for

effects of excessive myelosuppression. Avoid use with narcotics, hypnotics or

sedatives and monitor patients receiving the combination for effects of

excessive CNS toxicity.

USE IN SPECIFIC POPULATIONS

* Pregnancy: Based on mechanism of action and the role of interferon alfa in

pregnancy and fetal development, BESREMi may cause fetal harm and should

be assumed to have abortifacient potential when administered to a pregnant

woman. There are adverse effects on maternal and fetal outcomes associated

with polycythemia vera in pregnancy. Advise pregnant women of the

potential risk to a fetus.

* Lactation: There are no data on the presence of BESREMi in human or animal

milk, the effects on the breastfed child, or the effects on milk

production. Because of the potential for serious adverse reactions in

breastfed children from BESREMi, advise women not to breastfeed during

treatment and for 8 weeks after the final dose.

* Females of Reproductive Potential: BESREMi may cause embryo-fetal harm

when administered to a pregnant woman. Pregnancy testing prior to BESREMi

treatment is recommended for females of reproductive potential. Advise

female patients of reproductive potential to use effective contraception

during treatment with BESREMi and for at least 8 weeks after the final

dose.

* Pediatric Use: Safety and effectiveness in pediatric patients have not

been established.

* Geriatric Use: In general, dose selection for an elderly patient should be

cautious, usually starting at the low end of the dosing range, reflecting

the greater frequency of decreased hepatic, renal, or cardiac function and

of concomitant disease or other therapy.

hunter5582 profile image
hunter5582 in reply tosocrates_8

I did, of course, check out the IFNs thoroughly before deciding to use them. Fortunately, I have no hx of depression so I was not unduly concerned about that issue. I have an issue with arrhythmia, but it has not been a problem with the PEG. I doubt Besremi will be any different.

The whole COVID infection certainly made things worse. She was apparently asymptomatic but had to be on the COVID unit, which meant we could not visit her. I could not visit anyone since I contracted it. I suspect we were both exposed in this truly dreadful Rehab facility that the hospital originally discharged her to. Crummy place overall and COVID is rampant there. There were several staff there not bothering with proper mask protocol. The rest of the care was terrible too.

I hope your Mother's birthday can be safe and enjoyable for her. Perhaps the unvaccinated sibs will take over additional responsibilities since their choices are affecting other family members. One can only hope.

All the best my friend

socrates_8 profile image
socrates_8 in reply tohunter5582

Hey Steve...

Hoping that your Besremi journey continues in a positive manner...

As to my siblings... One believes that God told her NOT to be vaccinated, (BTW this is that same Christian deity so popular in many forums - father to JC etc).

Apparently, she has little comprehension of her mother's age & general health, not to mention her rare blood type...

In any event, I have finally managed to arrange her 3rd Booster, fingers crossed now is about the best I can hope for, I suppose...

The level of uninformed ignorance out there I find stupefying... The absurdity of being a human being... (?)

Cheers buddy, stay safe, happy & well...

Steve

hunter5582 profile image
hunter5582 in reply tosocrates_8

How odd. I am pretty sure that same God was just fine with me getting vaccinated 3x. One wonders just to whom is talking when they are hearing such irrational things. Perhaps is as the Church Lady on the old Saturday Night Live sketches used to exclaim.

All the best to you and your Mom,

socrates_8 profile image
socrates_8 in reply tohunter5582

Yes correct Steve, and as one other simple cliche usefully depicts, "...fact is often stranger than fiction..." although seeking clarity where none exists is another of those ill–defined "wicked problems" in my view...

I've thought long and hard about questions such as these, and many others that have plagued my perception & understanding concerning the nature & actioned rational of humanity, (& what we know of historicity).

In my simple analogy, we are all driven by the central desire to first serve "self"...

I warned you it was simple!

Pertaining to self amusement, I sometimes feel a tad like an Alien race swept across our world one night, (must've been a night where I actually slept for more than an hour uninterrupted), and during that brief foray, they replaced my family w/ facsimile clones, and I know longer recognise those family members, nor their logical application to problem solving in this 'Brave New World' where far more has been laid bare & let loose from Pandora's box..

Pardon the puns, couldn't resist the temptation, ever feel such urges yourself Steve?

Best wishes buddy... ;-)

Steve

kristinmarie profile image
kristinmarie in reply tosocrates_8

Wow! The list of cautions and warnings are very long for this expensive drug ($7,500 per dose), and yet a user will end up throwing most of it away.

nightshadow profile image
nightshadow

Hope all works well for you

Thankfulone profile image
Thankfulone

Praying that all goes well for you. Also for peace for your mother in her closing hours. And for yourself. Losing a loved one is difficult and painful even though there can be relief to see the suffering end.

Alliswell4me_ profile image
Alliswell4me_

Best wishes on your Besremi journey! You’re such an inspiration for self-advocacy and staying the course for your continuing health. Thank you!1

mother2britton profile image
mother2britton

Sorry to hear about your mother. You have a lot going on, stay strong , get plenty of rest and keep healthy. Best wishes.

Wyebird profile image
Wyebird

Hope all goes well do keep us informed

Piperpeeps profile image
Piperpeeps

Thank you for the update! Good luck! I hope everything turns out as expected.

Jynx93 profile image
Jynx93

Hope it all goes well for you, good luck

Adlon57 profile image
Adlon57

Keep in touch👍👍

Mustang50 profile image
Mustang50

Good luck & best wishes really hope this works well for you .

Kelly2 profile image
Kelly2

Good luck! Please keep us posted! Are the injections intravenous?? And why don't they arrange for more people to have the rest of the medicine at the same time and thus not waist it?

mickey64 profile image
mickey64

Hi Hunter, just seeing this. Who is your Dr at Hopkins I also go to Hopkins and I have been on Besrimi since last April 2022. I'm up to 200, not much improvement yet but still hopeful!

hunter5582 profile image
hunter5582 in reply tomickey64

I was seeing Dr. Braunstein but he left Hopkins. Now seeing Dr. Tania Jain. Have some more recent updates, the short version being that on 150mcg Besremi my allele burden has dropped from 38% to 9% but recently liver enzymes are up and needed to do a phlebotomy as HCT = 47.9%. Could not raise the Besremi dose due to the LFTs. First phlebotomy in over 2 years though. On the whole, very pleased with the response to Besremi.

gjh8733 profile image
gjh8733

It’s interesting reading about others starting on besremi and titrations up slowly. I was put on it mid Sept last and my oncologist has ramped it up every 2 weeks do that now I am at 500 ug the top dose. Still needed a phlebotomy 2 weeks ago and oncologist view is it can 6-10 mts to see an effect. Luckily no obvious side effects to date……

hunter5582 profile image
hunter5582 in reply togjh8733

It is interesting how differently we all respond to Besremi. It speaks to how important individualized care is in treating MPNs. We all need hematologists with the requisite expertise in these rare disorders to ensure optimal individualized care.

Glad to hear that you are tolerating the besremi so well at the maximum dose. Wishing you all the best moving forward.

RyanCB profile image
RyanCB

Hey Hunter - I too am a patient of Dr. Jain. I have PV w/JAK2 mutation (diagnosed in 2018). Went through typical protocol:

-Phlebotomy

-Hydroxyurea

-Jakafi

Referred to JohnsHopkins in Dec 2022. Dr Jain recommended switching to Besremi. Started my first dose (100mg) Dec 21 2022, second dose (150mg) Jan3 and my third dose (200mg) Jan 18. No real side effects (thankfully) but platelets have been increasing quickly since being off Jakafi. Yesterday's PLT was 1146. And my potassium levels are high. Not sure if this is due to high PLT counts or possible issues with Besremi... I have to hydrate today and go in for another CMP panel.

Anyways - let's stay in touch since we are both seeing Dr. Jain and on Besremi.

Cheers.

hunter5582 profile image
hunter5582

I have been through several MPN Specialists at Johns Hopkins. Dr. Jain is a great doc. Glad to be consulting with her now. It sounds like you have both erythrocytosis and thrombocytosis as a function of the PV. I have this same profile, but my PLT have never been as high as yours. I have responded well to the Besremi at 150mcg. This seems to be the max dose I can tolerate at this point. You can read more about my journey with Besremi in my updated posts.

Suggest you talk to Dr. Jain about the possibility of pseudohyperkalemia, which can be associated with thrombocytosis. Others on the forum have reported this as well.

Do let's stay in touch.

Not what you're looking for?

You may also like...

Besremi Adverse Effect??

I have experienced what may be arthralgia as a Besremi adverse effect. here is the exchange with...
hunter5582 profile image

Update 6.2

Besremi dose 2 is today. Things are actually looking pretty good and I will be sticking with the...
hunter5582 profile image

Eight months: Besremi Update

UPDATE: 9/12/2022 two weeks after previous CMP. Besremi dose at 150mg. My ALT was is the normal...
Elizka profile image

How quickly to increase Besremi dose?

I've taken my first 100mcg dose of Besremi and would like to hear from others how much they...

Update 6.7

A few items of note. CBC numbers are pretty stable from two weeks ago. HCT is OK at 45.3%. PLT...
hunter5582 profile image

Moderation team

Debinha profile image
DebinhaAdministrator
Mazcd profile image
MazcdPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.